Citation: Holtz TH, Holmes S, Stonington S, Eisenberg L (2006) Health Is Still Social: Contemporary Examples in the Age of the Genome. PLoS Med 3(10): e419. https://doi.org/10.1371/journal.pmed.0030419
Published: October 24, 2006
Copyright: © 2006 Holtz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors received no specific funding for this article.
Competing interests: The authors have declared that no competing interests exist.
In 1999, Leon Eisenberg wrote an essay entitled, “Does social medicine still matter in an era of molecular medicine?” . Anticipating the scientific discussion that would accompany the complete mapping of the human genome, followed by hubristic predictions of an end to disease through the introduction of gene-based therapy, Eisenberg reminded his readers of the inherent social basis of disease causation. “The developments in molecular biology highlight the salience of the social environment and underscore the urgency to rectify inequity and injustice. All medicine is inescapably social,” he wrote.
In this Essay, we revisit those concerns and expand them to discuss the current state of scholarship on the social causes of, experiences of, and responses to disease. We contend that social medicine is as important now as it has ever been. The field of social medicine includes various social and cultural studies of health and medicine , and in this article, we will focus on one domain of these studies—the social roots of disease—to illustrate the contemporary importance of social medicine.
The final sequencing of the human genome was announced in 2001 and greeted with great fanfare. Scientists have since cloned the embryo of a sheep, followed by a dog, cow, horse, mule, and mouse. With automated DNA sequencing, the genetic code may soon be cracked for nearly every major animal phylum. Many scientists are hopeful that these developments will eventually produce laboratory-based gene therapies that will cure many human diseases. What is invariably lost in these celebrations of scientific advances is awareness that human social organization is the primary determinant of how diseases are distributed in society, and that much of human disease results from preventable social factors. This inextricable link between social inequality and ill health is seen in nearly every field of medicine.
As a first example, consider the recent global environmental disasters, which, natural or unnatural, laid bare the inequalities that cut across society. The years 2004 and 2005 were terrible years for “natural” disasters—the Asian tsunami on December 26, 2004 , Hurricane Katrina in September 2005 , and the Kashmir earthquake in October 2005 . Although nature triggered these events, there was nothing “natural” about the extent to which certain people were more likely to die. All disasters are shaped by the context and hierarchy of human social organization.
The role of human behavior and social organization in determining who was at risk is an ignored but vital aspect of disasters. In a landmark study, sociologist Eric Kleinenberg, researching the Chicago heat wave of 1995, found that the mortality attributed to the disaster could only be fully understood with a “social autopsy” of the event. Without “de-naturalizing” the event, its outcomes and its relationship with social inequalities and local policies remained obscure .
(Photo: Waving Goodbye, Abigail Hankin)
There is no better illustration of the need for a social autopsy of a disaster than the devastation wrought on urban New Orleans and surrounding communities by Hurricane Katrina . Because of extensive flooding in the city, more than 75% of the city's 500,000 residents became internally displaced virtually overnight. Most of those who could not escape the storm were poor, living in historically economically deprived communities. Many of these communities were also predominately African American, such as the hard-hit Lower Ninth Ward. Most residents who stayed behind and bore the full impact of the category 5 hurricane (it was downgraded to category 3 by the time it hit the coast) did not have the luxury of choosing to leave; they had no option but to stay. They had neither cars nor ready access to transport for evacuation. Who lived or died was more a reflection of available housing and transportation options, not biologic risk factors. The disaster may have been “natural” in a meteorological sense (although some now argue that global warming has increased the probability of hurricanes), but it was the “unnatural” social forces—specifically class and race—that determined who lived and who died.
Though Katrina unfolded before our eyes on television, greater tragedy has been playing out for centuries in United States society in morbidity and mortality differentials between socially defined racial groups, particularly between whites and blacks. The overall death rate for African Americans, today, is comparable to the rate for white Americans some 30 years ago. This translates into 100,000 African Americans dying every year (most from chronic diseases) who otherwise would not die if the death rates were similar between the two groups . Disparities in infectious diseases at the beginning of the 20th century are now being replicated in disparities in cardiovascular disease, cancer outcomes, and many other chronic diseases at the beginning of the 21st century .
Although the prevalence of heart disease and diabetes is two to three times higher in African Americans than in whites, representative surveys of Caribbean populations of African origin have revealed prevalence rates two to five times lower than those of blacks in America or Britain . This should give pause to those searching for solely biologic explanations of racial disparities in disease. The disparities in these rates in the US are partially due to socially patterned behaviors. The persistent differences are also strongly related to social disparities such as residential segregation, neighborhood quality, and labor conditions that create, contribute to, and exacerbate ill health . In addition, white and black patients presenting with the same signs and symptoms are given significantly different medical care, based on their perceived racial or ethnic identity .
Despite pernicious associations between race and inequality, modern medicine pushes ahead with efforts to produce race-specific therapy for diseases such as heart disease and diabetes. In June 2005, the first “race-specific” patented drug (isosorbide dinitrate combined with hydralazine hydrochloride, or BiDil) was approved for the treatment of heart failure in African Americans . The drug is a combination of two generic medications that have been off patent for years and widely used to control heart failure. Through clever marketing, the combination drug was presented to the US Food and Drug Administration as a “race-specific” drug, after initially being denied a patent—the first US drug to be based on a patent formulated in terms of its benefit to a specific racial group. The approval of BiDil presages a trend in the pharmaceutical industry to use race as a proxy “genetic” biologic marker to address health disparities through commercial drug development . What might be called the “desocializing” or “geneticizing” of race has potentially worrisome implications (discussed in ).
Distribution of health care.
Julian Tudor Hart, who served as a primary-care physician for Welsh miners for more than 30 years , established a clinical research practice based on medical surveillance of his entire population of 1,900 patients (rather than limiting his purview to the fraction who attended his surgery). From this experience, Hart coined the “Inverse Care Law” : “The availability of good medical care varies inversely with the need for it in the population served. . . [all the] more completely where medical care is most exposed to market forces . . ” Even in a nationalized health system such as in the United Kingdom, resource distribution reflects the social status of communities and determines the health of the people in them .
Only 10% of the world's health research funding goes toward the diseases that make up 90% of the global burden, a situation known as the “10/90 gap.” Traditionally, pharmaceutical companies have focused their research on diseases of the rich world. Fortunately there has been a recent surge in the pharmaceutical industry's engagement in developing drugs for the neglected diseases of poverty .
The Foundation for Change in the Field
In 1848, the German physician Rudolf Virchow laid the foundation for the practice of social medicine, and advocated that medicine be reformed on the basis of three principles: (1) the health of the people is a matter of direct social concern; (2) social and economic conditions have an important effect on health and disease, and these relations must be subjected to scientific investigation; and (3) the measures taken to promote health and to combat disease must be social, as well as medical .
In the 150 years since Virchow produced his principles, medicine has strayed from this vision . Despite television images of trapped hurricane survivors searching for food and the knowledge that 44 million Americans (most of them working) do not have health insurance, medical research continues its biomedical trajectory in search of expensive “magic bullets” and more sophisticated interventional technologies, rather than understanding the social determinants of health. The field of medicine needs to return to Virchow's principles and highlight the social, as well as the biological risks, for disease. We need to recognize that relative positions in society affect health, exposure to illness, risk for illness-producing behaviors, and the patient's sense of agency.
Though science has become more interdisciplinary in nature, the disciplines invited to the table do not always include the social sciences. The door is slightly ajar and must be pried open. As Karl Popper reminds us, “We are not students of some subject matter, but students of problems. And problems may cut across the borders of any subject matter or discipline .”
Why then is social science often excluded? For one, academic medicine has been preempted by the glamour of technology and by the rewards it brings to those who discover and employ it . For another, social scientists are unwelcome when they discover unpleasant facts, such as life circumstances trumping medical care in determining the health status of populations and that disparities in health care are part of the system rather than oversights . These discoveries not only threaten medical hegemony, but they challenge the larger social order .
The Roots of Disease Are Still Social
We cannot look at the status of a population's health without examining the social context. Consider the risk of exposure, host susceptibility, course of disease, and disease outcome; each is shaped by the social matrix, whether the disease is labeled “infectious,” “genetic,” “metabolic,” “malignant,” or “degenerative.”
The distribution of health and disease in human populations reflects where people live; when in history they live; the air they breathe and the water they drink; what and how much they eat; the energy they expend; the work they do; the status they occupy in the social order and how they are socialized to respond to and identify with or resist this status; who, when, and whether they marry; whether they are socially isolated or rich in friends; the amount and kind of medical care they receive; and whether they are stigmatized when sick or receive care in the community. This is no new discovery. The Hippocratic Treatise “Airs, Waters, Places” enjoins, “whoever wishes to pursue properly the science of medicine” to consider, among other features of the place of practice, “the mode of life . . . of the inhabitants, whether they are heavy drinkers, taking lunch and inactive, or athletic, industrious, eating much and drinking little.”
Contemporary medical indifference to “mode of life” is a legacy of, among other things, the spectacular accomplishments of bacteriology in the late-19th century, which made single causes and single effects the paradigm for medical theory. But the paradigm is flawed. Bacteria do not fully account for disease pathogenesis. Infection by the tubercle bacillus is a necessary, but not sufficient, condition for clinical tuberculosis. Of individuals with a primary infection (evidenced by a positive tuberculin skin test), only a minority ever display the symptoms and signs of clinical disease. Susceptibility to tuberculosis varies not only with age and sex but also with housing and social class . Mortality data for England and Wales show that the death rate from tuberculosis had already fallen by half during the 40 years before Koch discovered the bacillus. During the next 60 years, it fell by more than half again before effective chemotherapy (streptomycin) was introduced . Decreasing morbidity and mortality rates reflected improved living conditions.
We cannot confine our alleviation of suffering to patient biology.
Enormous health disparities exist in this century around the world. Life expectancy ranges from 34 years in Sierra Leone to 82 years in Japan . There is a marked social gradient within countries: households with more wealth, higher incomes, better education, and safer jobs (socioeconomic status) have lower mortality rates. The gap in life expectancy between the most-advantaged and the least-advantaged populations in the US is 20 years. What social conditions give rise to or contribute to increased risk for disease? Unhealthy behaviors and life stressors contribute to and exacerbate disease risk, but “the health of the population is a measure of whether, in the end, that population is benefiting as the result of a set of its social arrangements .”
From Understanding to Action
Michael Marmot, chairman of the World Health Organization's Commission on Social Determinants of Health, said that “if the major determinants of health are social, so must be the remedies. Health status is the best measure of whether a population is thriving” .
Complex health problems are insoluble without understanding social context. There is an urgent need for social scientists, and in particular physician social scientists, to participate in interdisciplinary research. Training in existing disciplines should be broadened so that graduates become aware of the concepts and methods at the borders of their fields. Basic scientists should be introduced to clinical problems; clinical investigators should be kept abreast of laboratory disciplines.
Training physicians in social science.
We need to create the minimum expectation that all physicians be trained as “informed consumers” of social science, able to recognize implications applicable to their own work . Beyond this, our contemporary world needs practitioners dually trained in medicine and the social sciences. We need scholars who can produce social analysis grounded in suffering, and who are committed to ameliorating that suffering. And we need humanist scholars who can unveil the experience of suffering and health care. These physician scholars will be those best suited to guide medical education in the areas of social disparities in health, cultural competency, and beyond.
Developing a “community-side manner.”
If we want to fulfill our role as medical professionals, we cannot confine our alleviation of suffering to patient biology. Our bedside manner should be extended to an informed “community-side manner” that considers all the social contributing factors to human health.
Currently, the time constraints and scope of medical practice make it difficult for practitioners to develop this skill—to question their own narrow training, to explore and understand the social forces that affect their patients, and to intervene beyond bodies and into social worlds. The version of the Hippocratic Oath most commonly used in medical schools today states that “I will apply, for the benefit of the sick, all measures which are required.” The social contract for physicians to improve the health of those who are suffering necessitates broader, societal interventions [28–30]. Clinicians must tackle this challenge by incorporating social concepts into their daily practice and becoming a powerful voice in the public debate. During the Katrina “unnatural disaster,” David Brooks made a simple yet profound observation: “Floods wash away the surface of society, the settled way things have been done. They expose the underlying power structures, the injustices, the patterns of corruption and the unacknowledged inequalities”.
Only systematic change can reverse the disparities that we observe today, to transform the heavy mantle of inequality into action to change the fundamental causation of disease. We need to act on an existing social science knowledge base and add to that foundation through systematic research. It is our professional obligation to address inequities caused by larger social forces, both local and worldwide, which create and perpetuate inequality and poor health.
The authors would like to acknowledge the contribution and insight of several colleagues with whom these ideas were discussed, including Brandon Kohrt, Barry Levy, Anne-Emanuelle Birn, Alyssa Finlay, C. Lanny Smith, Dan O'Connell, Dabney Evans, and Jay Kaufman. Our thanks go to Susan Moscou and Karina Celaya for their thoughtful reviews of the manuscript.
- 1. Eisenberg L (1999) Does social medicine still matter in an era of molecular medicine? J Urban Health 76: 164–175.
- 2. King NMP, Henderson G, Oberlander J (2005) The social medicine reader. Durham: Duke University Press.
- 3. VanRooyen M, Leaning J (2005) After the tsunami—Facing the public health challenges. N Engl J Med 352: 435–438.
- 4. McLellan F (2005) Hurricane Katrina: “A speaking sight”, or, washday in Durant. Lancet 366: 968–969.
- 5. Brennan RJ, Waldman RJ (2006) The South Asian earthquake six months later—An ongoing crisis. N Engl J Med 354: 1769–1771.
- 6. Klinenberg E (1999) Denaturalizing disaster: A social autopsy of the 1995 Chicago heat wave. Theory Soc 28: 239–295.
- 7. Klinenberg E (2005) Session 3—Learning lessons: Social consequences of Katrina. Understanding Katrina; 2005 11 November; New York. Columbia University. Available: http://www.earthinstitute.columbia.edu/crosscutting/cciseminars/2005fall/katrina-11-11.htm. Accessed 10 September 2006.
- 8. Satcher D, Fryer GE Jr, McCann J, Troutman A, Woolf SH, et al. (2005) What if we were equal? A comparison of the black-white mortality gap in 1960 and 2000. Health Aff (Millwood) 24: 459–464.
- 9. Williams DR, Jackson PB (2005) Social sources of racial disparities in health. Health Aff (Millwood) 24: 325–334.
- 10. Cruickshank JK, Mbanya JC, Wilks R, Balkau B, McFarlane-Anderson N, et al. (2001) Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Int J Epidemiol 30: 111–117.
- 11. Nelson ARInstitute of Medicine [US], Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Stith AY, Smedley BD (2003) Unequal treatment: Confronting racial and ethnic disparities in health care. Washington (D. C.): National Academy Press.
- 12. Kahn J (2005) From disparity to difference: How race-specific medicines may undermine policies to address inequalities in health care. South Calif Interdiscip Law J 15: 105–130.
- 13. Sankar P, Kahn J (2005) BiDil: Race medicine or race marketing? Health Aff (Millwood). E-pub ahead of print 11 October 2005.
- 14. Garcia RS (2004) The misuse of race in medical diagnosis. Pediatrics 113: 1394–1395.
- 15. Moorhead R (2004) Hart of Glyncorrwg. J R Soc Med 97: 132–136.
- 16. Hart JT (1971) The inverse care law. Lancet 1: 405–412.
- 17. Evans T (2001) Challenging inequities in health: From ethics to action. Oxford (United Kingdom); New York: Oxford University Press.
- 18. Moran M (2005) A breakthrough in R&D for neglected diseases. New ways to get the drugs we need. PLoS Med 2: e302. DOI: https://doi.org/10.1371/journal.pmed.0020302.
- 19. Virchow RLK, Rather LJ (1985) Collected essays on public health and epidemiology. Canton (Massachusetts): Science History Publications.
- 20. Waitzkin H (1981) The social origins of illness: A neglected history. Int J Health Serv 11: 77–103.
- 21. Popper KR (1989) Conjectures and refutations: The growth of scientific knowledge. New York: Routledge.
- 22. Sotelo J (2006) Regulation of clinical research sponsored by pharmaceutical companies: A proposal. PLoS Med 3: e306. DOI: https://doi.org/10.1371/journal.pmed.0030306.
- 23. Farmer P (2006) The uses of Haiti. Monroe (Maine): Common Courage Press.
- 24. Glassroth J, Robins AG, Snider DE Jr (1980) Tuberculosis in the 1980s. N Engl J Med 302: 1441–1450.
- 25. McKeown T (1979) The role of medicine: Dream, mirage, or nemesis? Princeton (New Jersey): Princeton University Press.
- 26. Marmot M (2005) Social determinants of health inequalities. Lancet 365: 1099–1104.
- 27. Pellmar TC, Brandt EN Jr, Baird MA (2002) Health and behavior: The interplay of biological, behavioral, and social influences: Summary of an Institute of Medicine report. Am J Health Promot 16: 206–219.
- 28. Rosen G (1974) From medical police to social medicine: Essays on the history of health care. New York: Science History Publications.
- 29. Scheper-Hughes N (1992) Death without weeping: The violence of everyday life in Brazil. Berkeley (California): University of California Press.
- 30. Holmes SM (2006) An ethnographic study of the social context of migrant health in the United States. PLoS Med 3: e448. DOI: https://doi.org/10.1371/journal.pmed.0030448.
- 31. Brooks D (2005 September 1) The storm after the storm. The New York Times; Section A: 23.